BiotechTube

Roxadustat + Darbepoetin alfa

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anemia in Chronic Kidney Disease in Non-dialysis Patients

Conditions

Anemia in Chronic Kidney Disease in Non-dialysis Patients

Trial Timeline

Mar 12, 2014 → Nov 6, 2019

NCT ID
NCT02021318

About Roxadustat + Darbepoetin alfa

Roxadustat + Darbepoetin alfa is a phase 3 stage product being developed by Astellas Pharma for Anemia in Chronic Kidney Disease in Non-dialysis Patients. The current trial status is completed. This product is registered under clinical trial identifier NCT02021318. Target conditions include Anemia in Chronic Kidney Disease in Non-dialysis Patients.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT02952092Phase 3Completed
NCT02021318Phase 3Completed
NCT01888445Phase 2Completed

Competing Products

20 competing products in Anemia in Chronic Kidney Disease in Non-dialysis Patients

See all competitors
ProductCompanyStageHype Score
Aranesp®AmgenApproved
84
KER-047Keros TherapeuticsPhase 2
44
LY2787106Eli LillyPhase 1
33
R744 + R744Chugai PharmaceuticalPhase 3
77
epoetin beta + placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietin placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietinChugai PharmaceuticalPhase 3
77
darbepoetin alfaAmgenPhase 3
76
PrasugrelDaiichi SankyoPhase 1
33
Prasugrel + PlaceboDaiichi SankyoPhase 2
52
roxadustatAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77
AlefaceptAstellas PharmaPhase 1
33
RoxadustatAstellas PharmaPhase 2
52
roxadustatAstellas PharmaPhase 1
33
Roxadustat + PlaceboAstellas PharmaPhase 3
77
RoxadustatAstellas PharmaPre-clinical
23
Roxadustat + Epoetin AlfaAstellas PharmaPhase 3
77
roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85